Professionals working in social services, probation, parole, drug courts, corrections, and reentry programs share a singular mission: helping individuals rebuild their lives and successfully reintegrate into the community. For clients affected by Opioid Use Disorder (OUD), access to immediate, evidence-based treatment is one of the most powerful tools for reducing recidivism and improving long-term stability.Â
MedMark Treatment Centers provides accredited, confidential, and comprehensive Medication-Assisted Treatment (MAT) designed to support the unique needs of justice-involved individuals. Our programs serve as a critical bridge between the judicial system and sustained recovery.Â
Our outpatient model addresses both the clinical and social challenges faced by individuals transitioning back into the community.Â
We combine FDA-approved medications—methadone and buprenorphine (Suboxone)—with individualized counseling to stabilize withdrawal symptoms, reduce cravings, and support psychological healing. Our case management team works closely with each client to build a personalized treatment plan that ensures continuity, accountability, and follow-through with required services.Â
We understand that maintaining structure is essential for successful reentry.Â
MedMark supports accountability through:Â
This model helps clients maintain progress while meeting their legal and personal commitments.Â
Together, we can provide your clients with a second chance at a healthy, stable, and fulfilling life.Â
Decades of research confirm that MAT—medication paired with behavioral therapy—is the gold standard for reducing overdose risk, illicit opioid use, and justice involvement.Â
Lowering Rearrest RatesÂ
Individuals engaged in MAT demonstrate significantly fewer arrests and re-incarcerations, contributing to safer communities and reduced system burden.Â
Increasing Treatment RetentionÂ
MAT dramatically improves retention in treatment—one of the strongest predictors of long-term recovery success.Â
Decreasing Post-Release MortalityÂ
The first weeks post-release carry a sharply elevated risk of fatal overdose. MAT provides a life-saving stabilizing bridge, reducing that risk and supporting safe community reentry.Â
By partnering with MedMark, you provide clients with a clinically proven pathway away from crisis and toward meaningful, long-term change.Â
Clients enter a nonjudgmental, supportive setting where dignity is prioritized. Beyond medication, MedMark provides:Â
We strictly follow 42 CFR Part 2 and HIPAA regulations, ensuring that all information sharing with judicial partners occurs only with signed authorization.Â
Our clinical team utilizes evidence-based therapies tailored to justice-involved individuals navigating stress, triggers, and reentry challenges.Â
These interventions support long-term stability and reduce reliance on substances as a coping mechanism.Â
We prioritize rapid linkage to care. Contact your local MedMark center to coordinate a timely intake and minimize delays that could jeopardize client stability.
Many locations offer or coordinate transportation resources. Availability varies, so please check with your local center.
With a signed 42 CFR Part 2-compliant release, MedMark can share attendance, treatment engagement, and medication status with designated officials.Â
MedMark accepts Medicaid, Medicare, commercial insurance, and various state-funded programs. We also work to ensure financial barriers do not prevent treatment participation.Â
Contact your nearest MedMark Treatment Center to establish a judicial partnership, coordinate referrals, or create streamlined processes that meet your agency’s needs.Â